Page last updated: 2024-08-23

du-21220 and Cancer of Ovary

du-21220 has been researched along with Cancer of Ovary in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jóźwik, M; Kleszczewski, T; Kostrzewska, A; Modzelewska, B; Pędzińska-Betiuk, A; Sulkowski, S	1

Other Studies

1 other study(ies) available for du-21220 and Cancer of Ovary

Article	Year
Altered uterine contractility in response to β-adrenoceptor agonists in ovarian cancer. The journal of physiological sciences : JPS, 2017, Volume: 67, Issue:6 Topics: Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Adult; Aged; Aged, 80 and over; Dioxoles; Endometrial Neoplasms; Ethanolamines; Female; Humans; Middle Aged; Ovarian Neoplasms; Receptors, Adrenergic, beta; Ritodrine; Uterine Contraction	2017

Article

Year

Altered uterine contractility in response to β-adrenoceptor agonists in ovarian cancer.

The journal of physiological sciences : JPS, 2017, Volume: 67, Issue:6

Topics: Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Adult; Aged; Aged, 80 and over; Dioxoles; Endometrial Neoplasms; Ethanolamines; Female; Humans; Middle Aged; Ovarian Neoplasms; Receptors, Adrenergic, beta; Ritodrine; Uterine Contraction

2017